HomeRCUS • NYSE
add
Arcus Biosciences Inc
Previous close
$19.83
Day range
$18.63 - $19.98
Year range
$6.50 - $22.11
Market cap
2.35B USD
Avg Volume
1.60M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 26.00M | -45.83% |
Operating expense | 27.00M | -10.00% |
Net income | -135.00M | -46.74% |
Net profit margin | -519.23 | -170.90% |
Earnings per share | -1.27 | -27.00% |
EBITDA | -140.00M | -35.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 831.00M | -23.69% |
Total assets | 974.00M | -22.20% |
Total liabilities | 538.00M | -21.69% |
Total equity | 436.00M | — |
Shares outstanding | 107.97M | — |
Price to book | 4.88 | — |
Return on assets | -34.65% | — |
Return on capital | -56.94% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -135.00M | -46.74% |
Cash from operations | -97.00M | -473.08% |
Cash from investing | 79.00M | 372.41% |
Cash from financing | 8.00M | -83.33% |
Net change in cash | -10.00M | -122.22% |
Free cash flow | -41.62M | -172.95% |
About
Founded
2015
Website
Employees
627
